PACS Group (NYSE:PACS) CEO Jason Hulse Murray Sells 31,358 Shares of Stock

Key Points

• CEO Jason Hulse Murray sold 31,358 PACS Group shares at an average of $46.02, for about $1.44 million. The sale was made under a pre-arranged Rule 10b5-1 plan and reduced his ownership by 0.06%; he retained roughly 54.1 million shares.
• PACS Group reported quarterly EPS of $0.63 and revenue of $1.50 billion, beating analyst estimates of $0.58 and $1.46 billion, respectively.
• Analysts’ consensus rating is “Moderate Buy”, with an average price target of $58.80; five analysts rate the stock Buy and two rate it Hold.

PACS Group, Inc. (NYSE:PACS - Get Free Report) CEO Jason Murray sold 31,358 shares of the stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $46.02, for a total transaction of $1,443,095.16. Following the completion of the transaction, the chief executive officer directly owned 54,148,039 shares of the company's stock, valued at approximately $2,491,892,754.78. This trade represents a 0.06% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Wednesday, November 4th, Jason Murray sold 167,434 shares of PACS Group stock. The shares were sold at an average price of $50.24, for a total transaction of $8,411,884.16.
• On Tuesday, November 3rd, Jason Murray sold 26,504 shares of PACS Group stock. The stock was sold at an average price of $46.50, for a total value of $1,232,436.00.
• On Thursday, October 29th, Jason Murray sold 1,904 shares of PACS Group stock. The stock was sold at an average price of $50.05, for a total value of $95,295.20.
• On Wednesday, October 28th, Jason Murray sold 6,899 shares of PACS Group stock. The stock was sold at an average price of $50.10, for a total value of $345,639.90.
• On Friday, October 23rd, Jason Murray sold 68,917 shares of PACS Group stock. The shares were sold at an average price of $48.60, for a total value of $3,349,366.20.
• On Thursday, October 22nd, Jason Murray sold 13,696 shares of PACS Group stock. The shares were sold at an average price of $47.55, for a total value of $651,244.80.
• On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The stock was sold at an average price of $47.62, for a total value of $314,768.20.
• On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The stock was sold at an average price of $47.65, for a total value of $1,785,779.05.
• On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The shares were sold at an average price of $47.57, for a total value of $77,063.40.
• On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The shares were sold at an average price of $47.61, for a total value of $402,875.82.

PACS Group Price Performance

Shares of PACS stock traded up $3.95 during mid-day trading on Wednesday, reaching $50.63. The stock had a trading volume of 1,790,293 shares, compared to its average volume of 895,995. PACS Group, Inc. has a 12-month low of $10.31 and a 12-month high of $51.68. The company has a market cap of $8.01 billion, a P/E ratio of 29.44, a price-to-earnings-growth ratio of 1.42 and a beta of -0.14. The business has a 50-day simple moving average of $44.29 and a 200 day simple moving average of $39.85. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21.

PACS Group (NYSE:PACS - Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.05. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. The business had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.46 billion. On average, sell-side analysts anticipate that PACS Group, Inc. will post 2.13 earnings per share for the current year.

Institutional Trading of PACS Group

Several institutional investors and hedge funds have recently made changes to their positions in PACS. Dimensional Fund Advisors LP boosted its stake in shares of PACS Group by 370.2% during the first quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company's stock valued at $25,051,000 after acquiring an additional 614,250 shares during the last quarter. Sei Investments Co. boosted its stake in shares of PACS Group by 7.4% during the first quarter. Sei Investments Co. now owns 370,501 shares of the company's stock valued at $11,900,000 after acquiring an additional 25,462 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in PACS Group by 44.6% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company's stock worth $9,274,000 after purchasing an additional 89,067 shares in the last quarter. Bank of New York Mellon Corp purchased a new stake in PACS Group during the 2nd quarter worth about $8,196,000. Finally, Corient Private Wealth LP increased its position in PACS Group by 1.8% during the 2nd quarter. Corient Private Wealth LP now owns 152,846 shares of the company's stock worth $6,517,000 after purchasing an additional 2,680 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on PACS. Wall Street Zen cut shares of PACS Group from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 8th. Weiss Ratings upgraded shares of PACS Group from a "hold (c)" rating to a "hold (c+)" rating in a research report on Thursday, October 8th. Royal Bank Of Canada increased their price target on shares of PACS Group from $52.00 to $57.00 and gave the company an "outperform" rating in a research report on Thursday, August 6th. Zacks Research cut shares of PACS Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, September 9th. Finally, JPMorgan Chase & Co. lifted their price objective on PACS Group from $47.00 to $58.00 and gave the stock an "overweight" rating in a research report on Friday, September 4th. Five equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, PACS Group currently has an average rating of "Moderate Buy" and a consensus target price of $58.80.

PACS Group News Summary

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: PACS reported third-quarter 2026 earnings of $0.63 per share, above estimates of $0.56–$0.58 and up from $0.32 a year earlier. Revenue of $1.50 billion also topped forecasts of $1.46 billion, supporting the positive market reaction. PACS Group, Inc. Reports Third Quarter 2026 Results PACS Group Q3 Earnings and Revenues Beat Estimates
• Negative Sentiment: CEO Jason Murray, director Mark Hancock, and chief accounting officer Michelle Lewis reported share sales. The sales could raise a modest concern about insider sentiment, but they were conducted under Rule 10b5-1 plans; Murray and Hancock continued to hold roughly 54 million shares each. CEO Form 4 filing Director Form 4 filing Chief accounting officer Form 4 filing

About PACS Group

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company's operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.